𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Matrix Metalloproteinase 2 (MMP-2) Immunoreactive Protein is Associated with Poor Grade and Survival in Brain Neoplasms

✍ Scribed by Juha Jäälinojä; Riitta Herva; Merja Korpela; Matti Höyhtyä; Taina Turpeenniemi-Hujanen

Book ID
110235238
Publisher
Springer US
Year
2000
Tongue
English
Weight
139 KB
Volume
46
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Matrix metalloproteinase-2 (MMP-2) immun
Matrix metalloproteinase-2 (MMP-2) immunoreactive protein?a new prognostic marker in uveal melanoma?
✍ V�is�nen, Anne; Kallioinen, Matti; von Dickhoff, Kai; Laatikainen, Leila; H�yhty 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB 👁 2 views

Uveal melanoma is the most common primary intraocular tumour. Once haematogenous metastasis has occurred, there is no cure for the disease and there is an obvious need for new biological prognostic markers to estimate the risk of metastasis. In this study, the expression of matrix metalloproteinase-

Expression of membrane type 1 matrix met
Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization
✍ Nor Eddine Sounni; Eugenia N. Baramova; Carine Munaut; Erik Maquoi; Francis Fran 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 778 KB

## Abstract Membrane‐type metalloproteinase‐1 (MT1‐MMP) is a transmembrane metalloproteinase overexpressed in tumors, which plays a major role in the first step of pro‐MMP‐2 activation, leading to the generation of an intermediate 62 kDa species. The second step of MMP‐2 activation that yields to t